Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Generalized Social Anxiety Disorder
NCT00260533Phase 3Completed
- Sponsor
- University of California, San Diego
- Start
- Nov 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of atomoxetine in generalized social anxiety disorder (GSAD), sponsored by University of California, San Diego. Started Nov 2005; status: completed.
02
Drugs
atomoxetine
03
Conditions
generalized social anxiety disorder (GSAD)
Beyond the preview
Go deeper on NCT00260533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260533.